FDA approves dual monoclonal antibody therapy for some COVID-19 cases

Health Check: FDA gives emergency approval to antibody therapy for COVID-19Подробнее

FDA approves COVID-19 antibody treatment for high-risk patientsПодробнее

FDA stops two antibody treatments for COVID-19Подробнее

FDA approves Eli Lilly treatmentПодробнее

FDA Approves Antibody Drug For COVID-19 TreatmentПодробнее

FDA Approves Regeneron’s Covid-19 Antibody Treatment | NBC Nightly NewsПодробнее

Daily Covid-19 Minute: The FDA Authorizes Their First Monoclonal Antibody Therapy For Use In Covid-1Подробнее

Eli Lilly antibody therapy approved by FDAПодробнее

FDA Authorizes New Long-Acting Monoclonal AntibodiesПодробнее

FDA Approves Antibody Treatment For Kids Under 12Подробнее

New COVID-19 treatment for immunocompromised in TampaПодробнее

FDA approves antibody treatment as preventative after exposure to COVIDПодробнее

FDA approves antibody treatment for emergency useПодробнее

New COVID antibody treatment gets FDA approvalПодробнее

Coronavirus Update: FDA gives emergency approval for antibody treatmentПодробнее

FDA approves AstraZeneca's antibody cocktailПодробнее

FDA: Some antibody treatments don't work against omicron, pulls emergency use authorizationПодробнее

FDA authorizes emergency use of experimental coronavirus therapyПодробнее

New COVID-19 treatment authorized by FDA - Eli Lilly's Bamlanivimab (LY-CoV555) monoclonal antibodyПодробнее